Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Organogenesis Holdings Inc. - Class A (NQ:ORGO)

4.275 +0.015 (+0.35%)
Streaming Delayed Price Updated: 2:51 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Organogenesis Holdings Inc. - Class A

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Why Organogenesis Holdings Blasted 7.7% Higher Today
The company will be a component of a high-profile stock index. 
Via The Motley Fool
Topics Stocks
41 Stocks Moving In Thursday's Mid-Day Session
Gainers 1847 Goedeker Inc. (NYSE: GOED) shares jumped 156.5% to $11.08 after dropping over 8% on Wednesday. Vertex Energy, Inc. (NASDAQ: VTNR) jumped 117% to $3.8604 after the... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Zosano Pharma (NASDAQ:ZSAN) stock moved upwards by 22.59% to $0.91 during Thursday's pre-market session. The company's market cap stands at $97.3 million.... 
Via Benzinga
Earnings Scheduled For May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... 
Via Benzinga
Stocks That Hit 52-Week Highs On Friday
During the morning session on Friday, 178 stocks hit new 52-week highs. Noteworthy Points: Microsoft (NASDAQ:MSFT) was the largest firm on a market cap basis to set... 
Via Benzinga
24 Stocks Moving in Thursday's Pre-Market Session
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) rose 82% to $3.24 in pre-market trading after the company announced plans to acquire a Alabama refinery and related logistics assets.... 
Via Benzinga
Organogenesis Holdings Inc (ORGO) Q1 2021 Earnings Call Transcript
ORGO earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Organogenesis Holdings: Q1 Earnings Insights
Shares of Organogenesis Holdings (NASDAQ:ORGO) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 143.75% year over... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Vir Biotechnology (NASDAQ:VIR) sha... 
Via Benzinga
Earnings Outlook for Organogenesis Holdings
Organogenesis Holdings (NASDAQ:ORGO) releases its next round of earnings this Monday, May 10. Here is Benzinga's essential guide to Organogenesis Holdings's Q1 earnings report.... 
Via Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Obalon Therapeutics (NASDAQ:OBLN)... 
Via Benzinga
Repligen Stock Gets Relative Strength Rating Upgrade With Earnings Due
A Relative Strength Rating upgrade for Repligen shows improving technical performance. Will it continue? 
Via Investor's Business Daily
Medical Device Maker Quanterix Sees Relative Strength Rating Rise To 86
On Tuesday, Quanterix stock hit an important technical milestone, with its Relative Strength (RS) Rating rising into to 86, up from 80 the day before. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of... 
Via Benzinga
Align Technology Nears Buy Point With Earnings Due
Align Technology is near a possible buy zone ahead of its next quarterly earnings report, expected on or around April 28. 
Via Investor's Business Daily
Cancer Therapy Novocure Stock Still On A High As It Clears Technical Benchmark
Cancer therapy Novocure stock had its Relative Strength (RS) Rating upgraded from 90 to 93 Wednesday. It's also an IBD 50 member. 
Via Investor's Business Daily
Cancer Therapy Novocure Stock Flashes Renewed Technical Strength
Novocure stock saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 67 to 92. 
Via Investor's Business Daily
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8) Aclaris Therapeutics, Inc... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.